MedTrace Logo

The Effect of Dexmedetomidine on Kidney Function in EVAR

NCT04766047 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2021-04-28

No results posted yet for this study

Summary

This study will investigate the effect of dexmedetomidine on the incidence of postoperative acute kidney injury in patients undergoing EVAR under general anesthesia

Conditions

Interventions

DRUG

Dexmedetomidine

Administration of dexmedetomidine intraoperatively

Sponsors & Collaborators

  • University of Thessaly

    lead OTHER

Principal Investigators

  • Eleni Arnaoutoglou, MD, PhD · University of Thessaly

  • Konstantinos Stamoulis, MD, PhD · University Hospital of Larissa

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-30
Primary Completion
2023-11-30
Completion
2024-02-01

Countries

  • Greece

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04766047 on ClinicalTrials.gov